Stay Ahead of The Curve

Keep up with rapidly developing perspectives on aging via our curated news and events feed.

  1. Adult Immunization and the Pillars of Prevention

    The central narrative lays out three pillars that are essential to the new prevention paradigm for the 21st century, centered around adult immunization: Innovative Medicines, Vaccines and Models: Scaling Breakthroughs to Unlock Prevention Resilient Health Systems: Creating Readiness for a Super-Aging Society Smart Aging Investments: Maximizing the Full Value of Longevity for Workforces and Communities 

  2. Report on Cardiovascular Disease and the Case for Prevention

    This new GCOA paper, published alongside the launch of the Aging with Heart Alliance, provides an analysis of cardiovascular disease (CVD) as the leading global cause of death and underscores the urgent need for a prevention-based approach. With the world undergoing an unprecedented aging megatrend, CVD prevention is more critical than ever, as aging populations…

  3. Report on the Silver Economy Forum 2024

    Held in Berlin, Germany, on October 15th and 16th, and the United Nations Headquarters in New York City on December 3rd, 2024, Silver Economy Forum 2024: Leadership in an Aging World explored the opportunities associated with the growing global Silver Economy in a world of changing leadership and discussed what’s needed for successful leadership across issues…

  4. Issue Brief: Solving for Antimicrobial Resistance, A Rising Global Health and Humanitarian Crisis

    On November 12, 2024, the Global Coalition on Aging and the Acton Institute brought together a diverse group of thought leaders—including senior clergy, scientists, G7 leaders, patient advocates, and private sector innovators—at the Pontifical Academy of Sciences in Vatican City for a critical discussion on antimicrobial resistance (AMR). The event, entitled Solving for Antimicrobial Resistance:…

  5. Report on the Economic Burden of RSV in APEC Countries

    In December 2024, IQVIA released a new white paper, developed in collaboration with GSK and GCOA, examining the significant economic and clinical burden of Respiratory Syncytial Virus (RSV) in older adults (age ≥60 years) across select high-income APEC countries, including China, Japan, South Korea, Canada, Singapore, New Zealand, Australia, Hong Kong, and Taiwan. The study…

Claim your seat at the table